(C) World Health Organization
This story was originally published by World Health Organization and is unaltered.
. . . . . . . . . .
Hepatitis B virus drug resistance: Updates, unanswered questions, key challenges, and the roadmap for the future [1]
[]
Date: 2024-11-19
Background
As part of World AMR Resistance Awareness Week (WAAW) 2024, join us for WHO’s first-ever webinar focused on hepatitis B virus (HBV) drug resistance. This groundbreaking event will explore both current knowledge and critical knowledge gaps in HBV drug resistance. It comes at a timely moment, as WHO is developing an Integrated Global Action Plan (I-GAP) for drug resistance prevention, monitoring, and response across HIV, viral hepatitis, and priority sexually transmitted infections spanning 2025-2030.
The I-GAP underscores the need for identifying risk factors, understanding the prevalence and geographic distribution of HBV drug resistance, and evaluating its clinical impact at the population-level. This webinar will present emerging strategies for preventing, monitoring and responding to HBV drug resistance, monitoring while highlighting key areas that require further investigation.
Objectives
To educate healthcare providers, public health professionals, and stakeholders on the potential challenges of HBV drug resistance, advocate for addressing knowledge gaps, and provide a roadmap for the future. This aligns with the WAAW 2024 theme: Educate. Advocate. Act Now.
What to expect
[END]
---
[1] Url:
https://www.who.int/news-room/events/detail/2024/11/19/default-calendar/hepatitis-b-virus-drug-resistance--updates--unanswered-questions--key-challenges--and-the-roadmap-for-the-future
Published and (C) by World Health Organization
Content appears here under this condition or license: Creative Commons CC-BY-NC-SA 3.0 IGO.
via Magical.Fish Gopher News Feeds:
gopher://magical.fish/1/feeds/news/who/
